Health

Obama Unveils Research Initiative to Develop Tailored Medical Treatments

President Barack Obama gestures as he speaks in the East Room of the White House in Washington, Friday, Jan. 30, 2015, calling for an investment to move away from one-size-fits-all-medicine, toward an approach that tailors treatment to your genes.  (AP Photo/Pablo Martinez Monsivais )
President Barack Obama gestures as he speaks in the East Room of the White House in Washington, Friday, Jan. 30, 2015, calling for an investment to move away from one-size-fits-all-medicine, toward an approach that tailors treatment to your genes. (AP Photo/Pablo Martinez Monsivais)

WASHINGTON (New York Times) — Declaring that “the possibilities are boundless,” President Obama on Friday announced a major biomedical research initiative, including plans to collect genetic data on one million Americans so that scientists can develop drugs and treatments tailored to the characteristics of individual patients.

Dr. Francis S. Collins, the director of the National Institutes of Health, said the studies would help doctors decide which treatments would work best for which patients.

White House officials said the “precision medicine initiative,” also known as personalized or individualized medicine, would begin with a down payment of $215 million in the president’s budget request for the fiscal year that starts on Oct. 1.

Precision medicine “gives us one of the greatest opportunities for new medical breakthroughs that we have ever seen,” Mr. Obama said at a White House event attended by patients’ advocates, researchers, and drug and biotechnology company executives. “The time is ripe to unleash a new wave of advances in this area, in precision medicine, just like we did with genetics 25 years ago,” Mr. Obama said. One study of that earlier effort, he said, found that “every dollar we spent to map the human genome has already returned $140 to our economy.”

READ MORE

Tags
Show More

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *


By submitting this form, you are consenting to receive marketing emails from: Washington Informer Newspaper, 3117 Martin Luther King Jr. Ave SE, Washington, DC, 20032, http://www.washingtoninformer.com. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

Back to top button

My News Matters to me - Washington Informer Donations

Be a Part of The Washington Informer Legacy

A donation of your choice empowers our journalists to continue the work to better inform, educate and empower you through technology and resources that you use.

Click Here Today to Support Black Press and be a part of the Legacy!

Subscribe today for free and be the first to have news and information delivered directly to your inbox.


By submitting this form, you are consenting to receive marketing emails from: Washington Informer Newspaper, 3117 Martin Luther King Jr. Ave SE, Washington, DC, 20032, http://www.washingtoninformer.com. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact
Close

Adblock Detected

Please consider supporting us by disabling your ad blocker